C Change Surgical

SurgiSLUSH™ generates 96% clinical support post-evaluation. Informed slush users recognize clinical & economic advantages of modern slush. Sealed Sterile Security: Lock out airborne contaminants and water-avid pathogens with sealed ChillVault™ containers. Users add hours of sealed protection and delete the extended ambient exposure required by traditional slush units. ChillVault™ containers enable visual confirmation of sterile barrier integrity before every use to avoid using contaminated slush for optimal sterile technique. Streamlined Workflow: SurgiSLUSH™ automates always-expert, ready-to-use slush. SurgiSLUSH™ users erase variable quality and distracting slush maintenance during challenging, complex cases. These days, teams appreciate no-fuss slush. Multi-Room Supply: Our users supply more slush with less labor, less waste & less equipment. SurgiSLUSH™ freezers reduce per-room equipment costs by 25%- 50%. Today’s teams get far more value & efficiency with sealed, auto-maintained supply. MARKET INFO: US clinical teams use over liters of sterile slush annually to topically cool and reduce an organ's need for oxygen, slow cellular damage and provide surgeons additional time for treatment in cardiac, organ procurement, transplant, urology, plastic and other complex surgeries. C Change Surgical holds over 30 US and foreign patents for sterile fluid temperature control and clinical automation. We licensed our first fluid control technology to a global, public company in 2010. HCA Contract GSA Contract Magnet Group Contract